Company / SG&A Expense
Pennant Group, Inc. SG&A Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$71.1M
FY2025
5-year range
$34.0M / $71.1M
FY2021-FY2025
Trend
+41.6%
vs FY2024
Sector context
#134 of 152
Health Care
What the data says
Pennant Group, Inc.'s sg&a expense of $71M is lower than 88% of companies in the Health Care sector (FY2025). SG&A Expense has increased for 3 consecutive years, from $34M in FY2022 to $71M in FY2025.
Based on SEC 10-K filings.
$71M in FY2025 with a 3-year CAGR of +27.9%.
Increased from $37M to $71M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +27.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 152This company $71.1M Sector average $182.7B
▼
-100.0% below sector average
Key checks
Key Insights
- Pennant Group, Inc.'s sg&a expense has grown for 3 consecutive years.
- 3-year CAGR of +27.9%, indicating consistent growth.
- In FY2025, sg&a expense increased 41.6% year-over-year.
- Ranks #134 out of 152 companies in the Health Care sector.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $71.1M | +41.6% |
| FY2024 | $50.2M | +36.9% |
| FY2023 | $36.7M | +7.9% |
| FY2022 | $34.0M | -6.3% |
| FY2021 | $36.3M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026